CD8:PA:PA- (EUR)

ETF | Others |

Last Closing

USD 157.1

Change

-1.12 (-0.71)%

Market Cap

USD 0.21B

Volume

700.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.60 (+0.31%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.31%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.65 (-0.27%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.15 (+0.48%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.15 (+0.30%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.16 (+0.35%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.27%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.46 (+0.40%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

+0.53 (+0.50%)

USD 4.29B

ETFs Containing CD8:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.76% 40% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.76% 39% F 55% F
Trailing 12 Months  
Capital Gain 9.52% 41% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.52% 39% F 61% D-
Trailing 5 Years  
Capital Gain 33.43% 48% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.43% 47% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.96% 60% D- 61% D-
Dividend Return 7.96% 57% F 60% D-
Total Return N/A 15% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 13.26% 54% F 73% C
Risk Adjusted Return 60.04% 60% D- 70% C-
Market Capitalization 0.21B 48% F 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.